Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK ... to buy 60 million doses of the vaccine in August if trials work out. It’s one of several agreements ...

A clinical trial has found that Novavax’ COVID-19 vaccine ... and should read out in a few weeks. UK Health Secretary Matt Hancock has previously said that approval of the vaccine would be ...

To watch more expert insights and analysis on the latest market action, check out ... its COVID-19 vaccine in children, triggering the first $50 million milestone payment from Sanofi. Novavax ...

The Company has achieved a milestone associated with its Phase 2/3 clinical trial for its COVID-19 vaccine in children, triggering the first $50 million milestone payment from Sanofi. Novavax (NVAX) ...

Pfizer was down 1.8%, along with U.S. shares of its COVID-19 vaccine partner, BioNTech, which fell 2%. Moderna dropped 1.8% and Novavax slipped 2.3%. Shares of packaged food companies including ...

Kennedy has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades. He disputes the anti-vaccine characterization and has said he ...

After a major increase in deaths from COVID-19 in December ... and staying home when sick even as vaccines roll out. “All of those things are still the most important thing we can do to prevent ...

The Company has achieved a milestone associated with its Phase 2/3 clinical trial for its COVID-19 vaccine in children, triggering the first $50 million milestone payment from Sanofi. Novavax ...

The World Health Organization's emergencies director on Friday praised the "fastest roll-out" of an Ebola vaccine trial in the midst of an epidemic, as Uganda responded to its latest outbreak.

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...